APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

IL-17 Monoclonal Antibody Injections

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global IL-17 Monoclonal Antibody Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Report ID 174001610328 December 2025175 pages

Choose your research edition.

Industry ResearchIL-17 Monoclonal Antibody Injections Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal IL-17 Monoclonal Antibody Injections Industry Growth and Trends Forecast to 203271 pages · $3,450 USDMarket StructureGlobal IL-17 Monoclonal Antibody Injections Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal IL-17 Monoclonal Antibody Injections Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal IL-17 Monoclonal Antibody Injections Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global IL-17 Monoclonal Antibody Injections market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for IL-17 Monoclonal Antibody Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IL-17 Monoclonal Antibody Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IL-17 Monoclonal Antibody Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for IL-17 Monoclonal Antibody Injections is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of IL-17 Monoclonal Antibody Injections include Novartis, Eli Lilly and Co., UCB and AstraZeneca, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global IL-17 Monoclonal Antibody Injections market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IL-17 Monoclonal Antibody Injections and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IL-17 Monoclonal Antibody Injections sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the IL-17 Monoclonal Antibody Injections market size, projected growth trends, production technologies, key applications, and end-use industries.

IL-17 Monoclonal Antibody Injections Segment by Company

Novartis

Eli Lilly and Co.

UCB

AstraZeneca

IL-17 Monoclonal Antibody Injections Segment by Type

Human Origin

Rat Origin

Other

IL-17 Monoclonal Antibody Injections Segment by Application

Hospital

Clinic

Other

IL-17 Monoclonal Antibody Injections Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IL-17 Monoclonal Antibody Injections market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IL-17 Monoclonal Antibody Injections and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IL-17 Monoclonal Antibody Injections.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the IL-17 Monoclonal Antibody Injections market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of IL-17 Monoclonal Antibody Injections manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of IL-17 Monoclonal Antibody Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of IL-17 Monoclonal Antibody Injections in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. IL-17 Monoclonal Antibody Injections Industry Trends Table 2. IL-17 Monoclonal Antibody Injections Industry Drivers Table 3. IL-17 Monoclonal Antibody Injections Industry Opportunities and Challenges Table 4. IL-17 Monoclonal Antibody Injections Industry Restraints Table 5. Global IL-17 Monoclonal Antibody Injections Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Manufacturers (2021-2026) Table 7. Global IL-17 Monoclonal Antibody Injections Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Manufacturers Table 9. Global IL-17 Monoclonal Antibody Injections Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global IL-17 Monoclonal Antibody Injections Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global IL-17 Monoclonal Antibody Injections Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global IL-17 Monoclonal Antibody Injections Manufacturers, Product Type & Application Table 13. Global IL-17 Monoclonal Antibody Injections Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global IL-17 Monoclonal Antibody Injections by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Human Origin Table 17. Major Manufacturers of Rat Origin Table 18. Major Manufacturers of Other Table 19. Global IL-17 Monoclonal Antibody Injections Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global IL-17 Monoclonal Antibody Injections Sales by Type (2021-2026) & (K Units) Table 21. Global IL-17 Monoclonal Antibody Injections Sales by Type (2027-2032) & (K Units) Table 22. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2026) Table 23. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2027-2032) Table 24. Global IL-17 Monoclonal Antibody Injections Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2026) & (K Units) Table 26. Global IL-17 Monoclonal Antibody Injections Revenue by Type (2027-2032) & (K Units) Table 27. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021-2026) Table 28. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Clinic Table 31. Major Manufacturers of Other Table 32. Global IL-17 Monoclonal Antibody Injections Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global IL-17 Monoclonal Antibody Injections Sales by Application (2021-2026) & (K Units) Table 34. Global IL-17 Monoclonal Antibody Injections Sales by Application (2027-2032) & (K Units) Table 35. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2026) Table 36. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2027-2032) Table 37. Global IL-17 Monoclonal Antibody Injections Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 38. Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2026) & (K Units) Table 39. Global IL-17 Monoclonal Antibody Injections Revenue by Application (2027-2032) & (K Units) Table 40. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021-2026) Table 41. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2027-2032) Table 42. Global IL-17 Monoclonal Antibody Injections Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global IL-17 Monoclonal Antibody Injections Sales by Region (2021-2026) & (K Units) Table 44. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Region (2021-2026) Table 45. Global IL-17 Monoclonal Antibody Injections Sales Forecasted by Region (2027-2032) & (K Units) Table 46. Global IL-17 Monoclonal Antibody Injections Sales Forecasted Market Share by Region (2027-2032) Table 47. North America IL-17 Monoclonal Antibody Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 48. North America IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 49. North America IL-17 Monoclonal Antibody Injections Sales by Country (2027-2032) & (K Units) Table 50. Europe IL-17 Monoclonal Antibody Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 51. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 52. Europe IL-17 Monoclonal Antibody Injections Sales by Country (2027-2032) & (K Units) Table 53. Asia Pacific IL-17 Monoclonal Antibody Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 55. Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Country (2027-2032) & (K Units) Table 56. South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2021-2026) & (K Units) Table 58. South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2027-2032) & (K Units) Table 59. Global IL-17 Monoclonal Antibody Injections Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global IL-17 Monoclonal Antibody Injections Revenue by Region (2021-2026) & (US$ Million) Table 61. Global IL-17 Monoclonal Antibody Injections Revenue by Region (2027-2032) & (US$ Million) Table 62. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2021-2026) Table 63. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2027-2032) Table 64. Novartis Company Information Table 65. Novartis Business Overview Table 66. Novartis IL-17 Monoclonal Antibody Injections Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Novartis IL-17 Monoclonal Antibody Injections Product Portfolio Table 68. Novartis Recent Development Table 69. Eli Lilly and Co. Company Information Table 70. Eli Lilly and Co. Business Overview Table 71. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolio Table 73. Eli Lilly and Co. Recent Development Table 74. UCB Company Information Table 75. UCB Business Overview Table 76. UCB IL-17 Monoclonal Antibody Injections Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. UCB IL-17 Monoclonal Antibody Injections Product Portfolio Table 78. UCB Recent Development Table 79. AstraZeneca Company Information Table 80. AstraZeneca Business Overview Table 81. AstraZeneca IL-17 Monoclonal Antibody Injections Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolio Table 83. AstraZeneca Recent Development Table 84. Key Raw Materials Table 85. Raw Materials Key Suppliers Table 86. IL-17 Monoclonal Antibody Injections Distributors List Table 87. IL-17 Monoclonal Antibody Injections Customers List Table 88. Research Programs/Design for This Report Table 89. Authors List of This Report Table 90. Secondary Sources Table 91. Primary Sources List of Figures Figure 1. IL-17 Monoclonal Antibody Injections Product Image Figure 2. Global IL-17 Monoclonal Antibody Injections Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IL-17 Monoclonal Antibody Injections Market Size (2021-2032) & (US$ Million) Figure 4. Global IL-17 Monoclonal Antibody Injections Sales (2021-2032) & (K Units) Figure 5. Global IL-17 Monoclonal Antibody Injections Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 IL-17 Monoclonal Antibody Injections Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Human Origin Image Figure 9. Rat Origin Image Figure 10. Other Image Figure 11. Global IL-17 Monoclonal Antibody Injections Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global IL-17 Monoclonal Antibody Injections Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2032) Figure 14. Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global IL-17 Monoclonal Antibody Injections Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global IL-17 Monoclonal Antibody Injections Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global IL-17 Monoclonal Antibody Injections Sales Market Share 2021 VS 2025 VS 2032 Figure 22. Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2032) Figure 23. Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 24. Global IL-17 Monoclonal Antibody Injections Revenue Market Share 2021 VS 2025 VS 2032 Figure 25. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021-2032) Figure 26. North America IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 27. North America IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2032) Figure 28. U.S. IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Canada IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Mexico IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 32. Europe IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2032) Figure 33. Germany IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 34. France IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 35. U.K. IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Italy IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Netherlands IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 39. Asia Pacific IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2032) Figure 40. China IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 41. Japan IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 42. South Korea IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Southeast Asia IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 44. India IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Australia IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 47. South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Market Share by Country (2021-2032) Figure 48. Brazil IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 49. South Africa IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Saudi Arabia IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Turkey IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 52. Argentina IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 53. UAE IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Egypt IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Chile IL-17 Monoclonal Antibody Injections Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Global IL-17 Monoclonal Antibody Injections Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 57. Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 58. North America IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Figure 59. North America IL-17 Monoclonal Antibody Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 60. Europe IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Figure 61. Europe IL-17 Monoclonal Antibody Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 62. Asia-Pacific IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Figure 63. Asia-Pacific IL-17 Monoclonal Antibody Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 64. South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue (2021-2032) & (US$ Million) Figure 65. South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. IL-17 Monoclonal Antibody Injections Value Chain Figure 67. Manufacturing Cost Structure Figure 68. IL-17 Monoclonal Antibody Injections Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Human Origin
  • Rat Origin
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Novartis
  • Eli Lilly and Co.
  • UCB
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global IL-17 Monoclonal Antibody Injections Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global IL-17 Monoclonal Antibody Injections Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global IL-17 Monoclonal Antibody Injections Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global IL-17 Monoclonal Antibody Injections Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global IL-17 Monoclonal Antibody Injections Market Dynamics
  1. 2.1 IL-17 Monoclonal Antibody Injections Industry Trends
  2. 2.2 IL-17 Monoclonal Antibody Injections Industry Drivers
  3. 2.3 IL-17 Monoclonal Antibody Injections Industry Opportunities and Challenges
  4. 2.4 IL-17 Monoclonal Antibody Injections Industry Restraints
3 IL-17 Monoclonal Antibody Injections Market by Manufacturers
  1. 3.1 Global IL-17 Monoclonal Antibody Injections Revenue by Manufacturers (2021-2026)
  2. 3.2 Global IL-17 Monoclonal Antibody Injections Sales by Manufacturers (2021-2026)
  3. 3.3 Global IL-17 Monoclonal Antibody Injections Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global IL-17 Monoclonal Antibody Injections Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global IL-17 Monoclonal Antibody Injections Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global IL-17 Monoclonal Antibody Injections Manufacturers, Product Type & Application
  7. 3.7 Global IL-17 Monoclonal Antibody Injections Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global IL-17 Monoclonal Antibody Injections Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 IL-17 Monoclonal Antibody Injections Players Market Share by Revenue in 2025
  11. 3.8.3 2025 IL-17 Monoclonal Antibody Injections Tier 1, Tier 2, and Tier 3
4 IL-17 Monoclonal Antibody Injections Market by Type
  1. 4.1 IL-17 Monoclonal Antibody Injections Type Introduction
  2. 4.1.1 Human Origin
  3. 4.1.2 Rat Origin
  4. 4.1.3 Other
  5. 4.2 Global IL-17 Monoclonal Antibody Injections Sales by Type
  6. 4.2.1 Global IL-17 Monoclonal Antibody Injections Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global IL-17 Monoclonal Antibody Injections Sales by Type (2021-2032)
  8. 4.2.3 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Type (2021-2032)
  9. 4.3 Global IL-17 Monoclonal Antibody Injections Revenue by Type
  10. 4.3.1 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global IL-17 Monoclonal Antibody Injections Revenue by Type (2021-2032)
  12. 4.3.3 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Type (2021-2032)
5 IL-17 Monoclonal Antibody Injections Market by Application
  1. 5.1 IL-17 Monoclonal Antibody Injections Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global IL-17 Monoclonal Antibody Injections Sales by Application
  6. 5.2.1 Global IL-17 Monoclonal Antibody Injections Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global IL-17 Monoclonal Antibody Injections Sales by Application (2021-2032)
  8. 5.2.3 Global IL-17 Monoclonal Antibody Injections Sales Market Share by Application (2021-2032)
  9. 5.3 Global IL-17 Monoclonal Antibody Injections Revenue by Application
  10. 5.3.1 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global IL-17 Monoclonal Antibody Injections Revenue by Application (2021-2032)
  12. 5.3.3 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Application (2021-2032)
6 Global IL-17 Monoclonal Antibody Injections Sales by Region
  1. 6.1 Global IL-17 Monoclonal Antibody Injections Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IL-17 Monoclonal Antibody Injections Sales by Region (2021-2032)
  3. 6.2.1 Global IL-17 Monoclonal Antibody Injections Sales by Region (2021-2026)
  4. 6.2.2 Global IL-17 Monoclonal Antibody Injections Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America IL-17 Monoclonal Antibody Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America IL-17 Monoclonal Antibody Injections Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe IL-17 Monoclonal Antibody Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe IL-17 Monoclonal Antibody Injections Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific IL-17 Monoclonal Antibody Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific IL-17 Monoclonal Antibody Injections Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global IL-17 Monoclonal Antibody Injections Revenue by Region
  1. 7.1 Global IL-17 Monoclonal Antibody Injections Revenue by Region
  2. 7.1.1 Global IL-17 Monoclonal Antibody Injections Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global IL-17 Monoclonal Antibody Injections Revenue by Region (2021-2026)
  4. 7.1.3 Global IL-17 Monoclonal Antibody Injections Revenue by Region (2027-2032)
  5. 7.1.4 Global IL-17 Monoclonal Antibody Injections Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America IL-17 Monoclonal Antibody Injections Revenue (2021-2032)
  8. 7.2.2 North America IL-17 Monoclonal Antibody Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe IL-17 Monoclonal Antibody Injections Revenue (2021-2032)
  11. 7.3.2 Europe IL-17 Monoclonal Antibody Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific IL-17 Monoclonal Antibody Injections Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific IL-17 Monoclonal Antibody Injections Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa IL-17 Monoclonal Antibody Injections Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis
  2. 8.1.1 Novartis Company Information
  3. 8.1.2 Novartis Business Overview
  4. 8.1.3 Novartis IL-17 Monoclonal Antibody Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Novartis IL-17 Monoclonal Antibody Injections Product Portfolio
  6. 8.1.5 Novartis Recent Developments
  7. 8.2 Eli Lilly and Co.
  8. 8.2.1 Eli Lilly and Co. Company Information
  9. 8.2.2 Eli Lilly and Co. Business Overview
  10. 8.2.3 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Eli Lilly and Co. IL-17 Monoclonal Antibody Injections Product Portfolio
  12. 8.2.5 Eli Lilly and Co. Recent Developments
  13. 8.3 UCB
  14. 8.3.1 UCB Company Information
  15. 8.3.2 UCB Business Overview
  16. 8.3.3 UCB IL-17 Monoclonal Antibody Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 UCB IL-17 Monoclonal Antibody Injections Product Portfolio
  18. 8.3.5 UCB Recent Developments
  19. 8.4 AstraZeneca
  20. 8.4.1 AstraZeneca Company Information
  21. 8.4.2 AstraZeneca Business Overview
  22. 8.4.3 AstraZeneca IL-17 Monoclonal Antibody Injections Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 AstraZeneca IL-17 Monoclonal Antibody Injections Product Portfolio
  24. 8.4.5 AstraZeneca Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 IL-17 Monoclonal Antibody Injections Value Chain Analysis
  2. 9.1.1 IL-17 Monoclonal Antibody Injections Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 IL-17 Monoclonal Antibody Injections Production Mode & Process
  6. 9.2 IL-17 Monoclonal Antibody Injections Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 IL-17 Monoclonal Antibody Injections Distributors
  9. 9.2.3 IL-17 Monoclonal Antibody Injections Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst